In 2023, Germany led European hypnotic and sedative medicine sales with 94.6 million Euros, followed by Belgium at 74.1 million Euros, and Spain at 60.9 million Euros. Lesser markets include Latvia, Austria, and Luxembourg, with respective sales of 5.1, 3.0, and 3.0 million Euros. Year-on-year variation in 2023 showed notable growth in Latvia at 9.77%, with Germany and Spain also experiencing increases of 3.08% and 2.17%, respectively. In contrast, Luxembourg saw a slight decline by 1.28%. Over the past five years, these markets have generally exhibited steady average annual growth.
Future trends to monitor in the European hypnotic and sedative market include potential shifts in regulatory policies, emerging market demand influenced by mental health awareness, and innovations in treatment efficacy. Watch for how these factors play a role in altering sales patterns across key countries.
Top countries in Hypnotic and Sedative Medicine Sales by Country
| # | 6 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 94.6 | 2023 | +0.11% | +3.08% | View data |
| 2 | 2 Belgium | 74.1 | 2023 | +0.68% | +0.027% | View data |
| 3 | 3 Spain | 60.9 | 2023 | +1.84% | +2.17% | View data |
| 4 | 4 Latvia | 5.1 | 2023 | +4.08% | +9.77% | View data |
| 5 | 5 Austria | 3 | 2023 | 0% | +1.39% | View data |
| 6 | 6 Luxembourg | 3 | 2023 | 0% | -1.28% | View data |
